Shil Cartilage

Anotusi

• Masalo le aoga mo ...
• Le lava molimau e fuaina aoga mo ...
• Lapataiga faʻapitoa & lapataʻiga:

Shark cartilage (uaua maʻaʻa maso e maua ai le lagolago, pei ona faia e ponaivi) faʻaoga mo vailaʻau e mafua mai lava i malie na maua i le Pasefika Vasa. E tele ituaiga o mea e aumai mai le shark cartilage e aofia ai le squalamine lactate, AE-941, ma le U-995.

Shark cartilage e sili ona lauiloa faʻaaogaina mo le kanesa. O loʻo faʻaaogaina le shark cartilage mo le osteoarthritis, maʻa o le psoriasis, leiloa o le vaʻai o tausaga, faʻamalologa o manuʻa, faʻaleagaina o le retina o le mata ona o le maʻisuka, ma le fulafula o le gaʻo (enteritis).

Nisi tagata faʻapipiʻi tuʻufaʻafanua tuʻusaʻo i le paʻu mo gugu ma psoriasis.

O nisi tagata e faʻapipiʻi le shark cartilage i le pito o le kanesa.

Natura Faʻafomaʻi Maea Faʻamatalaga fua faatatau aoga faʻavae i luga o faʻasaienitisi faʻamaoniga e tusa ma le fua faʻatatau lenei: Aoga, Masalo Lelei Lelei, E Lelei Lelei, Masalo Lelei Lelei, Masalo Lelei, Le Lelei, ma Le lava Faʻamaoniga e Fuafua ai.

Le aoga togi mo FUAFUAGA CARTILAGE e faapea:

Masalo le aoga mo ...

• Kanesa. O le tele o suʻesuʻega o loʻo faʻaalia ai, o le aveina o malie i le gutu e le aoga ai tagata e maua i kanesa o le susu, kolone, mama, prostate, poʻo le faiʻai ua uma na togafitia. E foliga mai e le aoga foi tagata i le alualu i luma, muamua togafitia non-Hodgkin's lymphoma. Shark cartilage e leʻi suʻesuʻeina i tagata e tau le maua i le kanesa.

Le lava molimau e fuaina aoga mo ...

• O le papala ole kanesa e taʻu ole Kaposi sarcoma. O loʻo iai lipoti e faʻapea o le faʻasusu malie i le paʻu atonu e faʻaititia ai tuma e taʻu o le Kaposi sarcoma. O nei tuma e sili ona taatele i tagata e maua ile HIV.
• Osteoarthritis. A faʻapipiʻi i le paʻu, o oloa o loʻo iai le shark cartilage faʻatasi ai ma isi mea na lipotia mai e faʻaititia ai faʻailoga o le gugu. Peitai, soʻo se faʻailoga fesoasoani e mafua mai i le camphor elemeni ae le o isi mea. E le gata i lea, e leai se suʻesuʻega e faʻaalia ai o le shark cartilage e mitiia i totonu o le paʻu.
• Suka. O le vave suʻesuʻe i tagata e iai le maama o le psoriasis o loʻo faʻaalia mai ai o le shark shark cartilage extract (AE-941) e faʻaleleia atili ai foliga o papamaa ma faʻaititia ai le mageso pe a ave e le gutu pe faʻapipiʻi i le paʻu.
• O se ituaiga kanesa o le fatugao e taʻua o le sela sela carcinoma. O le aveina o se shark cartilage extract (AE-941) e ala ile gutu e ono faʻateleina ai le ola o tagata mamaʻi e maua ai le kanesa o le sela.
• Leiloa tausaga le vaʻai vaʻai.
• Faamalologa manuʻa.
• Isi tulaga.

E tele faʻamaoniga e manaʻomia e fua ai le shil cartilage mo nei faʻaaogaina.

O le tanifa o le malie e ono le mafai ai ona tupu se toto fou e manaʻomia mo le kanesa. E ono mafai foʻi ona puipuia le tuputupu aʻe o ala toto i faʻamaʻi o le psoriasis. Atonu e fesoasoani lea e faʻamalolo ai nei manuʻa.

Shark cartilage o MAFAI ONA SAFIA mo le tele o tagata pe a fai e le gutu e oʻo atu i le 40 masina pe a faʻaoga i le paʻu e oʻo atu i le 8 vaiaso.

E mafai ona mafua ai se tofo leaga i le gutu, niniva, puaʻi, manava le fiafia, manava, maualalo le toto maualuga, niniva, maualuga toto suka, maualuga calcium maualuga, vaivaiga, ma le lelava. E ono aʻafia ai foʻi le ate. Nisi oloa maua se manogi leaga ma tofo.

Lapataiga faʻapitoa & lapataʻiga:

Maitaga ma susu-fafagaina: E le lava faʻamatalaga faʻatuatuaina e uiga i le saogalemu o le aveina o le shark cartilage pe a fai o oe o maʻito pe faʻasusu. Tumau i le itu saogalemu ma aloese mai le faʻaaogaina.

"Autoimmune faamaʻi" pei o le tele sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid gugu (RA), po o isi tulaga: O le shark cartilage e ono mafua ai le malosi o le tino puipuia. Lenei mafai faʻateleina auga o faʻamaʻi autoimmune. Afai e i ai se tasi o nei tulaga, e sili atu le aloese mai le faʻaaogaina o le cartilage shark.

Maualuga suka tulaga (hypercalcemia): O le shark cartilage atonu e faʻateleina ai le maualuga o le calcium, o lea e le tatau ai ona faʻaaogaina e tagata ua maualuga tele le maualuga ole suka.

Feololo

Faʻaeteete i lenei tuʻufaʻatasiga.

Vailaau e faʻaititia ai le puipuiga (Immunosuppressants)

O le shark cartilage e ono faʻateleina ai le puipuiga. I le faʻateleina o le puipuiga, o le shark cartilage e ono faʻaititia ai le aoga o vailaʻau e faʻaititia ai le puipuiga.

O ni vailaʻau e faʻaititia ai le puipuiga e aofia ai azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prac50 ), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), ma isi.

Kalisiu

Shark cartilage ono siʻitia le maualuga o le calcium. E i ai le popolega o le faʻaaogaina faʻatasi ai ma kalasiamu faʻaopopo e ono maualuga ai le maualuga o le calcium.

Sua suamalie

O fualaʻau sua oona e pei o moli, apu, vine, po o le tamato, e mafai ona tuʻu i lalo le malosi o le shark cartilage a o pasi atu minute. Afai o le shark cartilage ua faʻaopopoina i se fualaʻau sua, e tatau ona faʻaopopo saʻo aʻo leʻi faʻaaogaina.

O le fualaʻau talafeagai o le shark cartilage e faʻamoemoeina ile tele o mea taua e pei ole tausaga ole tagata faʻaaoga, soifua maloloina, ma le tele o isi tulaga. Ile taimi nei e le lava faʻamatalaga faʻasaienisi e fuafua ai le talafeagai o vailaʻau mo le shark cartilage. Manatua o mea masani e le masani ona saogalemu, ma e mafai ona taua ia vailaʻau. Ia mautinoa e mulimuli i faʻatonuga talafeagai i igoa oloa ma faʻafesoʻotaʻi lau fomaʻi poʻo le fomaʻi poʻo isi polofesa faʻapitoa ile soifua maloloina ae e te leʻi faʻaaogaina.

AE-941, Cartilage de Requin, Cartilage de Requin du Pacifique, Cartilago de Tiburon, Collagène Marin, Extrait de Cartilage de Requin, Liquide de Cartilage Marin, Marine Collagen, Marine Liquid Cartilage, MSI-1256F, Neovastat, Pacific Shark Cartilage, Poudre de Cartilage de Requin, Shark Cartilage Powder, Shark Cartilage Extract, Sphyrna lewini, Squalus acanthias.

Ina ia aoao atili e uiga i le auala na tusia ai lenei tusitusiga, faʻamolemole vaʻai i le Natura Faʻafomaʻi Maea Faʻamatalaga metotia

1. Merly L, Smith SL. Pro-inflammatory meatotino o le shark cartilage supplement. Immunopharmacol Immunotoxicol. 2015; 37: 140-7. Vaʻai faʻamatala.
2. Sakai S, Otake E, Toida T, Goda Y. Faʻailoaina o le amataga o chondroitin sulfate i "soifua maloloina soifua maloloina". Chem Pharm Bull (Tokyo). 2007; 55: 299-303. Vaʻai faʻamatala.
3. PDQ Integrative, Alternative, ma Faʻatumu Faʻapitoa Therapies Komiti Faʻatonu. Cartilage (Bovine ma Shark) (PDQ®): Soifua Maloloina Polokalama Faʻamatalaga. Aotelega Faamatalaga PDQ Kanesa [Initaneti]. Bethesda (MD): National Cancer Institute (US); 2002. 2016 Jul 21. Vaʻai faʻamatala.
4. Goldman E. Shark cartilage otoʻoto faʻataʻitaʻia pei o se tala psoriasis togafitiga. Paʻu Uma Tala 1998; 29:14.
5. Taumafa ma Vailaau Faʻafoeina. Ua faia e le FDA ni gaioiga faasaga i le mausali faʻatau maketi le taliaina. Pepa talanoa a le FDA (Tesema 10, 1999)
6. Lane W ma Milner M. O se faʻatusatusaga o le shark cartilage ma bovine cartilage. Townsend Lett 1996; 153: 40-42.
7. Zhuang, L, Wang, B, Shivji, G, ma isi al. AE-941, o se tala taofiofia angiogenesis ei ai taua taua anti-afaina i faʻafesoʻotaʻiga hypersensitivity. J Invest Derm 1997; 108: 633.
8. Turcotte P. Vaega I fualaʻau faʻateleina suʻesuʻega o AE-941, o se antiangiogenic sooupu, i tausaga-fesoʻotaʻi macular degeneration onosaʻi. Retina Society Conference (Hawaii, Tesema 2, 1999).
9. Saunder DN. Angiogenesis antagonist o togafitiga mo psoriasis: Vaega I falemaʻi faʻaiuga faʻaiuga ma AE-941. American Academy of Dermatology Conference, New Orleans, Louisiana, Mati 19-24, 1999.
10. Aeterna Laboratories Inc. Vaega III suʻesuʻeina o le AE-941 (Neovastat; Shark Cartilage Extract) i tagata mamaʻi ma metastatic renal cell carcinoma refactory i immunotherapy. 2001
11. Escudier, B, Patenaude, F, Bukowski, R, ma le al. Mafuaʻaga mo le vaega III faʻataʻitaʻiga faʻataʻitaʻi ma AE-941 (Neovastat (R)) i metastatic renal cell carcinoma tagata mamaʻi refactory i immunotherapy. Ann Oncol 2000; 11 (faʻaopoopoga 4): 143-144.
12. Dupont E, Alaoui-Jamali M, Wang T, ma et al. Gaioiga ole Angiostatic ma antitumoral ole AE-941 (Neovastat), o se vaega mole molemole na maua mai ile shark cartilage. Taualumaga a le American Association for Cancer Research 1997; 38: 227.
13. Shimizu-Suganuma, Masum, Mwanatambwe, Milanga, Iida, Kazum, ma et al. Aʻafiaga o le shark cartilage i luga o le tuputupu aʻe ma le ola taimi i vivo (fonotaga e le masani ai). Faʻafeiloaʻiga Annu Feiloai ia Am Soc Clin Oncol 1999; 18: A1760.
14. Faʻalauiloa Gaioiga ole Angiostatic ma le antitumoral o le AE-941 (neovastat-R), o se vaega ninii o le molelaa na maua mai i le shark cartilage (fonotaga e le masani ai). Faʻafeiloaʻi Annu Faʻafeiloaʻi Am Assoc Kanesa Res 1997; 38: A1530.
15. Cataldi, JM ma Osborne, DL. Aʻafiaga o le shark cartilage i mammary tumo neovascularization i vivo ma sela faateleina i vitro (fonotaga le masani ai). FASEB Tusi 1995; 9: A135.
16. Jamali MA, Riviere P, Falardeau A, ma le al. Aʻafiaga o le AE-941 (Neovastat), o le angiogenesis taofi, i le Lewis māmā carcinoma metastatic faʻataʻitaʻiga, aoga, faʻamalosiʻau puipuia ma ola. Clin Invest Med 1998; (supa): S16.
17. Saad F, Klotz L, Babaian R, Lacombe L, Champagne P, ma Dupont E. Phase I / II faʻamasinoga i luga o le AE-941 (Neovastat) i tagata mamaʻi ma le kanesa o le prostate refactoryastastastastast (abstract present). Fonotaga Faaletausaga a le Canadian Urological Association (Iuni 24-27, 2001).
18. Rosenbluth, RJ, Jennis, AA, Cantwell, S, ma et al. Laʻau malie tuʻu i le togafitia o tagata mamaʻi ua iai le faʻamaʻi muamua o le faiʻai. O le vaega II pailate suʻesuʻega (fonotaga a le auivi). Faʻafeiloaʻi Annu Faʻafeiloaʻi Am Soc Clin Oncol 1999; 18: A554.
19. Dupont E, Savard RE, Jourdain C, Juneau C, Thibodeau A, Ross N, ma et al. Antiangiogenic meatotino o se novel shark cartilage otoʻoto: mafai gaioiga i le togafitiga o psoriasis. J Cutan Med Surg 1998; 2: 146-152.
20. Lane IW ma Contreras E. Maualuga fua faatatau o le bioactivity (faʻaititia o le lapoʻa tele tuma lapoʻa) matauina i gasegase gasegase alualu i luma togafitia ma shark cartilage mea. J Naturopath Med 1992; 3: 86-88.
21. Wilson JL. O le cartilage shark autu e faʻatoʻilalo ai le psoriasis. Altern Comp Ther 2000; 6: 291.
22. Riviere M, Latreille J, ma Falardeau P. AE-941 (Neovastat), o se tagata taofiofi o angiogenesis: vaega I / II kanesa faʻaiuga faʻaiuga o faʻaiuga. Kanesa Faʻatupe 1999; 17 (sup 1): 16-17.
23. Milner M. O se taʻiala i le faʻaogaina o le shark cartilage i le togafitia o le gugu ma isi faʻamaʻi soʻoga o ponaivi. Amer Chiropractor 1999; 21: 40-42.
24. Leitner SP, Rothkopf MM, Haverstick DD, ma et al. Lua laʻasaga II suʻesuʻega o le tuʻuina o le shark shark cartilage powder (SCP) i tagata mamaʻi e iai le fatafata metastatic poʻo le kanesa o le prostate e faʻaaluina i togafitiga masani. Amer Soc Clin Oncol 1998; 17: A240.
25. Evans WK, Latreille J, Batist G, ma et al. AE-941, o se inhibitor o angiogenesis: mafuaʻaga mo atinae faʻatasi ma induction chemotherapy / radiotherapy i tagata mamaʻi ma le laiti-sela sela kanesa (NSCLC). Faʻasoaina Pepa 1999; S250.
26. Riviere M, Falardeau P, Latreille J, ma le al. Vaega I / II mama kanesa kanesa faʻaiuga faʻaiuga ma AE-941 (Neovastat ®) o se inhibitor o angiogenesis. Clin Invest Med (faʻaopoopoga) 1998; S14.
27. Riviere M, Alaoui-Jamali M, Falardeau P, ma le al. Neovastat: o se inhibitor o angiogenesis ma anti-kanesa gaioiga. Proc Amer Assoc Cancer Res 1998; 39:46.
28. Leai ni tusitala. Neovastat falemaʻi faʻataʻitaʻi faʻafitauli. 2001;
29. Aeterna Laboratories Inc. Vaega II suʻesuʻega o le AE-941 (Neovastat; Shark Cartilage) i tagata mamaʻi e vave ona toe solomuli pe faʻaola pea le tele o myeloma. 2001. Faʻamatalaga faʻafesoʻotaʻi numera 1-888-349-3232.
30. Fel pouzwalb, I., Pelielo de Mattos, J. C., Bernardo-Filho, M., ma Caldeira-de-Araujo, A. Shark cartilage-aofia ai sauniuniga: puipuiga mai ituaiga o okesene toe ola. Meaai Vaila Toxicol 1998; 36: 1079-1084. Vaʻai faʻamatala.
31. Coppes, M. J., Anderson, R. A., Egeler, R. M., ma Wolff, J. E. Isi togafitiga mo le togafitia o kanesa o tamaiti. N Engl.J Med 9-17-1998; 339: 846-847. Vaʻai faʻamatala.
32. Davis, P. F., He, Y., Furneaux, R. H., Johnston, P. S., Ruger, B. M., ma Slim, G. C. Le taofiofia o le angiogenesis e ala i le fofogaina o le paʻu o le cartilage shark efuefu i totonu o le rat model. Microvasc.Res 1997; 54: 178-182. Vaʻai faʻamatala.
33. McGuire, T. R., Kazakoff, P. W., Hoie, E. B., ma Fienhold, M. A. Antiproliferative gaioiga o le shark cartilage ma e aunoa ma tumo nekrosis factor-alpha i tagata umbilical vein endothelium. Pharmacotherapy 1996; 16: 237-244. Vaʻai faʻamatala.
34. Kuettner, K. E. ma Pauli, B. U. Le taofiofia o le neovascularization e ala i le cartilage factor. Ua maua Ciba. Symp. 1983; 100: 163-173.Vaʻai faʻamatala.
35. Lee, A. ma Langer, R. Shark cartilage o loʻo i ai mea e taofia ai le tuma angiogenesis. Saienisi 9-16-1983; 221: 1185-1187. Vaʻai faʻamatala.
36. Korman, D. B. [Antiangiogenic ma antitumor meatotino o le cartilage]. Vopr.Onkol. 2012; 58: 717-726. Vaʻai faʻamatala.
37. Patra, D. ma Sandell, L. J. Antiangiogenic ma anticancer molemoni i cartilage. Tomai Faʻapitoa. Rev Mol. Med 2012; 14: e10. Vaʻai faʻamatala.
38. de Mejia, E. G. ma Dia, V. P. O le matafaioi a le porotini o le nutritional protein ma peptides i le apoptosis, angiogenesis, ma le metastasis o sela kanesa. Kanesa Metastasis Rev 2010; 29: 511-528. Vaʻai faʻamatala.
39. Bargahi, A., Hassan, Z. M., Rabbani, A., Langroudi, L., Noori, S. H., ma Safari, E. Aafiaga o le shark cartilage maua protein i luga o le NK sela gaioiga. Immunopharmacol.Immunotoxicol. 2011; 33: 403-409. Vaʻai faʻamatala.
40. Lee, S. Y. ma Chung, S. M. Neovastat (AE-941) taofia le afaina o le ea e ala i le VEGF ma le HIF-2 alpha suppression. Vascul.Pharmacol 2007; 47 (5-6): 313-318. Vaʻai faʻamatala.
41. Pearson, W., Orth, M. W., Karrow, N. A., Maclusky, N. J., ma Lindinger, M. I. Aneti-afaina ma chondroprotective aafiaga o nutraceuticals mai Sasha's Blend i se cartilage explant faataitaiga o le fulafula. Mol Nutr Meaʻai Res 2007; 51: 1020-1030. Vaʻai faʻamatala.
42. Kim, S., de, A., V, Bouajila, J., Dias, AG, Cyrino, FZ, Bouskela, E., Costa, PR, ma Nepveu, F. Alpha-phenyl-N-tert-butyl nitrone ( PBN) mafuaʻaga: synthes ma puipuiga gaioiga faasaga microvascular faʻaleagaina faʻamalosia e ischemia / reperfusion. Bioorg. Med Chem 5-15-2007; 15: 3572-3578. Vaʻai faʻamatala.
43. Merly, L., Simjee, S., ma Smith, S. L. Faʻaosoina o cytokine mumusu e talaʻaga o le cartilage. Int Immunopharmacol. 2007; 7: 383-391. Vaʻai faʻamatala.
44. Moses, M. A., Sudhalter, J., ma Langer, R. Faʻailoaina o se inhibitor o neovascularization mai le gaʻoa. Saienisi 6-15-1990; 248: 1408-1410. Vaʻai faʻamatala.
45. Ratel, D., Glazier, G., Provencal, M., Boivin, D., Beaulieu, E., Gingras, D., ma Beliveau, R. Direct-acting fibrinolytic enzymes i shark cartilage otooto: ono togafitiga togafitiga i vascular faʻaletonu Faʻaputuga. 2005; 115 (1-2): 143-152. Vaʻai faʻamatala.
46. Gingras, D., Labelle, D., Nyalendo, C., Boivin, D., Demeule, M., Barthomeuf, C., ma Beliveau, R. O le antiangiogenic agents Neovastat (AE-941) faaosofia ai gaioiga plasminogen activator gaioiga. Inivesi Fou Vailaau 2004; 22: 17-26. Vaʻai faʻamatala.
47. Latreille, J., Batist, G., Laberge, F., Champagne, P., Croteau, D., Falardeau, P., Levinton, C., Hariton, C., Evans, WK, ma Dupont, E. Vaega I / II faʻataʻitaʻiga o le saogalemu ma le aoga o le AE-941 (Neovastat) i le togafitia o le le-laiti-sela sela kanesa. Clin Lung Kanesa 2003; 4: 231-236. Vaʻai faʻamatala.
48. Bukowski, R. M. AE-941, o se multifunctional antiangiogenic compound: o faʻataʻitaʻiga i le sela o le sela sela. Tomai Faʻapitoa.IpinInvestig.Drugs 2003; 12: 1403-1411. Vaʻai faʻamatala.
49. Jagannath, S., Champagne, P., Hariton, C., ma Dupont, E. Neovastat i le tele o myeloma. Eur.J.Haematol. 2003; 70: 267-268. Vaʻai faʻamatala.
50. E faʻatagaina e le FDA tulaga matuaoti-fualaʻau i Aeterna's Neovastat mo kanesa kanesa. Tagata tomai faapitoa. Rev Anticancer Ther 2002; 2: 618. Vaʻai faʻamatala.
51. Dupont, E., Falardeau, P., Mousa, SA, Dimitriadou, V., Pepin, MC, Wang, T., ma Alaoui-Jamali, MA Antiangiogenic ma antimetastatic meatotino a Neovastat (AE-941), o se tautala tuʻufaʻatasi upu e maua mai i le cartilage tissue. Clin Exp Metastasis 2002; 19: 145-153. Vaʻai faʻamatala.
52. Beliveau, R., Gingras, D., Kruger, EA, Lamy, S., Sirois, P., Simard, B., Sirois, MG, Tranqui, L., Baffert, F., Beaulieu, E., Dimitriadou, V., Pepin, MC, Courjal, F., Ricard, I., Poyet, P., Falardeau, P., Figg, WD, ma Dupont, E. O le Antiangiogenic Agent Neovastat (AE-941) Faʻatamaia le Vascular Endothelial Growth Factor -faʻatatauina Mamanuʻaiga Aafiaga. Togafitiga o le Kanesa Res 2002; 8: 1242-1250. Vaʻai faʻamatala.
53. Weber, M. H., Lee, J., ma Orr, F. W. O le aafiaga o Neovastat (AE-941) i luga o le faʻataʻitaʻi metastatic ponaivi faʻataʻitaʻi faʻataʻitaʻiga. Int J Oncol 2002; 20: 299-303. Vaʻai faʻamatala.
54. Barber, R., Delahunt, B., Grebe, S. K., Davis, P. F., Thornton, A., ma Slim, G. C. Oral shark cartilage e le faʻateʻaina le kanesa o le tino ae faʻatuai ai le faʻagasolo o le tino i se ata o le murine. Anticancer Res 2001; 21 (2A): 1065-1069. Vaʻai faʻamatala.
55. Gonzalez, RP, Soares, FS, Farias, RF, Pessoa, C., Leyva, A., Barros Viana, GS, ma Moraes, MO Faʻataʻitaʻiga o le taofiofia o aafiaga o tuugamau tuʻufaʻi i luga o le fibroblast tuputupu aʻe vaega-faʻaosofia angiogenesis i le lapiti Kornea Biol. Faʻafetai. 2001; 24: 151-154. Vaʻai faʻamatala.
56. Brem, H. ma Folkman, J. Faʻafitauli o le tumi angiogenesis faʻafesoʻotaʻiina e cartilage. J Exp.Med 2-1-1975; 141: 427-439. Vaʻai faʻamatala.
57. Koch, A. E. O le matafaioi a angiogenesis i le rheumatoid gugu: o mea na tutupu talu ai nei. Ann Rheum. 2000; 59 Faʻaopopo 1: i65-i71. Vaʻai faʻamatala.
58. Lauga, K. L. ma Harris, A. L. Tulaga nei o antiangiogenic mea. Br J Haematol. 2000; 109: 477-489. Vaʻai faʻamatala.
59. Morris, G. M., Coderre, J. A., Micca, P. L., Lombardo, D. T., ma Hopewell, J. W. Boron neutron puʻeina togafitiga o le iole 9L gliosarcoma: iloiloga o aʻafiaga o le shark cartilage. Br J Radiol. 2000; 73: 429-434. Vaʻai faʻamatala.
60. Renckens, C. N. ma van Dam, F. S. [O le tupe a le kanesa a le atunuʻu (Koningin Wilhelmina Fonds) ma le Houtsmuller-therapy mo kanesa]. Ned.Tijdschr.Geneeskd. 7-3-1999; 143: 1431-1433. Vaʻai faʻamatala.
61. Moses, MA, Wiederschain, D., Wu, I., Fernandez, CA, Ghazizadeh, V., Lane, WS, Flynn, E., Sytkowski, A., Tao, T., ma Langer, R. Troponin I o i ai i le tagata i atunuʻu ma taofia le angiogenesis. Faʻataʻitaʻiga Natl.Acad.Sci.U.S.A 3-16-1999; 96: 2645-2650. Vaʻai faʻamatala.
62. Moller HJ, Moller-Pedersen T, Damsgaard TE, Poulsen JH. Faʻataʻitaʻiga o le imulogenate keratin sulphate i pisinisi chondroitin 6-sulfate mai shark cartilage. Faʻamatalaga mo ELISA suʻega. Clin Chim Acta 1995; 236: 195-204. Vaʻai faʻamatala.
63. Lu C, Lee JJ, Komaki R, et al. Chemoradiotherapy ma pe leai AE-941 i le tulaga III le o laʻititi sela kanesa kanesa: o se randomized vaega III tofotofoga. J Natl Kanesa Inst 2010; 102: 1-7. Vaʻai faʻamatala.
64. Loprinzi CL, Levitt R, Barton DL, et al. Suʻesuʻega o le shark cartilage i tagata mamaʻi ma le kanesa alualu i luma: o le North Central Cancer Treatment Group faʻamasinoga. Kanesa 2005; 104: 176-82. Vaʻai faʻamatala.
65. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) i tagata mamaʻi sela sela o le fatu sela lipoti: lipoti o le laasaga II faʻataʻitaʻiga ma lua inumaga tulaga. Ann Oncol 2002; 13: 1259-63 .. Seʻi vaʻaia.
66. Sauder DN, Dekoven J, Champagne P, et al. Neovastat (AE-941), o se mea e taofiofi ai le angiogenesis: Faʻataʻitaʻiga laʻasaga I / II faʻataʻitaʻi faʻataʻitaʻiina faʻamaʻi i tagata mamaʻi ua iai le maʻi suka. J Am Acad Dermatol 2002; 47: 535-41. Vaʻai faʻamatala.
67. Gingras D, Renaud A, Mousseau N, et al. Matrix proteinase taofiofia e AE-941, o le multifunctional antiangiogenic compound. Anticancer Res 2001; 21: 145-55 .. Seʻi vaʻaia.
68. Falardeau P, Champagne P, Poyet P, et al. Neovastat, o se vailaʻau e masani ona tupu ai vailaʻau antiangiogenic, i le vaega III faʻataʻitaʻi falemaʻi. Semin Oncol 2001; 28: 620-5 .. Seʻi vaʻaia.
69. Boivin D, Gendron S, Beaulieu E, et al. O le antiangiogenic agents Neovastat (AE-941) faʻamalosia endothelial sela apoptosis. Mol Cancer Ther 2002; 1: 795-802 .. Vaʻaia faʻaaoga.
70. Cohen M, Wolfe R, Mai T, Lewis D. O se faʻasolosolo, faʻalua tauaso, placebo faʻataʻitaʻia faʻataʻitaʻia se kulimi kulimi o loʻo i ai le glucosamine sulfate, chondroitin sulfate, ma camphor mo osteoarthritis o le tulivae. J Rheumatol 2003; 30: 523-8 .. Seʻi vaʻaia.
71. Me B, Kuntz HD, Kieser M, Kohler S. Faʻatinoina o le faʻamautuina o le peppermint oil / caraway suauʻu tuʻufaʻatasia i le le papala dispepsia. Arzneimittelforschung 1996; 46: 1149-53. Vaʻai faʻamatala.
72. Anon Ua faalauiloa e le AEterna le amataina o le lesitalaina o tagata gasegase mo le NIH - lagolagoina le vaega III faʻataʻitaʻi faʻataʻitaʻiina o le AE-941 / Neovastat i le togafitia o le kanesa o le mama. Aeterna 2000 Tala Fou Faʻalauiloa 2000 Me 17.
73. Sheu JR, Fu CC, Tsai ML, Chung WJ. Aʻafiaga o U-995, o le malosi o le shark cartilage na maua mai i le angiogenesis inhibitor, luga o le anti-angiogenesis ma anti-tumo gaoioiga. Anticancer Res 1998; 18: 4435-41. Vaʻai faʻamatala.
74. Fontenele JB, Viana GS, Xavier-Filho J, de-Alencar JW. Aneti-afaina ma analgesic gaioiga o se vai-soluble vaega mai shark cartilage. Braz J Med Biol Res 1996; 29: 643-6. Vaʻai faʻamatala.
75. Fontenele JB, Araujo GB, de Alencar JW, Viana GS. O le analgesic ma anti-inflammatory aafiaga o le shark cartilage e mafua mai i le peptide moleki ma o nitric oxide (NO) faʻalagolago faʻavae. Biol Pharm Bull 1997; 20: 1151-4. Vaʻai faʻamatala.
76. Gomes EM, Souto PR, Felillionzwalb I. Shark-cartilage o loʻo iai sauniuniga e puipuia sela mai le hydrogen peroxide faʻatupuina faʻaleagaina ma mutagenesis. Mutat Res 1996; 367: 204-8. Vaʻai faʻamatala.
77. Mathews J. Media fafaga fagafao luga o shark cartilage o kanesa togafitiga. J Natl Kanesa Inst 1993; 85: 1190-1. Vaʻai faʻamatala.
78. Bhargava P, Trocky N, Marshall J, et al. O le vaega I le saogalemu, faʻapalepaleina ma faʻavasega vailaʻau o le siʻitia o fualaʻau, o loʻo alualu i luma le faʻaauau faifai pea o MSI-1256F (Squalamine Lactate) i tagata mamaʻi ua maua i le kanesa. Proc Am Soc Clinical Oncol 1999; 18: A698.
79. Kalidas M, Hammond LA, Patnaik P, et al. O le vaega I ma le vailaʻau (PK) suʻesuʻega o le tagata faʻatamaʻi le angiogenesis, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 2000; 19: A698.
80. Patnaik A, Rowinsky E, Hammond L, et al. O le vaega I ma le vailaʻau faʻasaina (PK) suʻesuʻega o le le masani ai le faʻatamaia o le angiogenesis, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 1999; 18: A622.
81. Evans WK, Latreille J, Batist G, et al. AE-941, o se inhibitor o angiogenesis: mafuaaga mo atinaʻe faʻatasi ma induction chemotherapy / radiotherapy i tagata mamaʻi ma le laiti sela sela kanesa (NSCLC). Proc Am Soc Clinical Oncol 1999; 18: A1938.
82. Rosenbluth RJ, Jennis AA, Cantwell S, DeVries J. Oral shark cartilage i le togafitia o tagata mamaʻi ma alualu i luma muamua faiʻai. O le vaega II pailate suʻesuʻega. Proc Am Soc Clinical Oncol 1999; 18: A554.
83. Leitner SP, Rothkopf MM, Haverstick L, et al. Lua laʻasaga II suʻesuʻega o le tautala tuʻu mamago shil cartilage paʻu (SCP) i tagata mamaʻi (pts) ma le metastatic fatafata poʻo le kanesa prostate faʻasolosolo i masani togafitiga. Proc Am Soc Clinical Oncol 1998; 17: A240.
84. Natl Kanesa Iniseti Kanesa Kanesa 'Upega tafaʻilagi Cartilage: www.cancer.gov (Avanoa i le 18 Aukuso 2000).
85. Berbari P, Thibodeau A, Germain L, et al Antiangiogenic aafiaga o le tautala tuʻuina o suavai suavai i tagata. J Surg Res 1999; 87: 108-13. Vaʻai faʻamatala.
86. Hillman JD, Peng AT, Gilliam AC, Remick SC. Togafitiga o Kaposi Sarcoma ma le tuʻufaʻatasia o le shark cartilage i le Human Herpes virus 8-seropositive, Human Immunodeficiency Virus-Seronegative homosexual man. Arch Dermatol 2001; 137: 1149-52. Vaʻai faʻamatala.
87. Neovastat falemaʻi faʻataʻitaʻi faʻafitauli. Faʻaalia i le American Association mo kanesa Suʻesuʻega 92 fonotaga faaletausaga. Mati 27, 2001.
88. Wilson JL. Laupapa shark cartilage toʻilalo psoriasis: suʻesuʻega iloiloina ma faʻamuamua falemaʻi taunuʻuga. Suʻesuʻega Faʻapitoa Ther 2000; 6: 291.
89. Miller DR, Anderson GT, Stark JJ, et al. Vaega I / II faʻataʻitaʻiga o le saogalemu ma le aoga o shark cartilage i le togafitia o le kanesa oʻo atu. J Clin Oncol 1998; 16: 3649-55. Vaʻai faʻamatala.
90. Lane IW, Comac L. O shark e le maua i le kanesa. Garden City, NY: Avery Publishing Group; 1992.
91. Hunt TJ, Connelly JF. Shark cartilage mo togafitiga o le kanesa. Am J Health Syst Pharm 1995; 52: 1756-60. Vaʻai faʻamatala.
92. Ashar B, Vargo E. Shark cartilage-faaosofia hepatitis [tusi]. Ann Intern Med 1996; 125: 780-1. Vaʻai faʻamatala.

Toe iloiloga - 03/14/2019